Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial.

Title: Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial.
Authors: Demeestere, Isabelle; Niman, Samuel M; Partridge, Ann H; Diego, Daniela S; Kammler, Roswitha; Ruggeri, Monica; Colleoni, Marco Angelo; Shimizu, Chikako; Saura, Cristina; Gelmon, Karen A; Saetersdal, Anna B; Kroep, Judith R; Mailliez, Audrey; Amant, Frédéric; Ruız-Borrego, Manuel; Lee, Jeong Eon; Kataoka, Akemi; Walshe, Janice M; Takei, Junko; Borstnar, Simona; Borges, Virginia F; Saunders, Christobel; Susnjar, Snezana; Bjelic-Radisic, Vesna; Cardoso, Fatima; Meisel, Jane Lowe; Kawwass, Jennifer Fay; Spanic, Tanja; El-Abed, Sarra; Piccart-Gebhart, Martine; Korde, Larissa A; Goldhirsch, Aron; Gelber, Richard D; Pagani, Olivia; Azim, Hatem A; Peccatori, Fedro A; International Breast Cancer Study Group and the POSITIVE Trial Collaborators
Source: Breast, 83
Publication Year: 2025
Collection: DI-fusion : dépôt institutionnel de l'Université libre de Bruxelles (ULB)
Subject Terms: Gynécologie; Cancérologie; Sciences biomédicales; Adult; Female; Humans; Pregnancy; Anti-Mullerian Hormone -- blood; Antineoplastic Agents; Hormonal; Breast Neoplasms -- drug therapy -- blood; Chemotherapy; Adjuvant; Fertility; Fertility Preservation -- methods; Follicle Stimulating Hormone -- blood; Ovarian Reserve -- physiology; Premenopause; Primary Ovarian Insufficiency -- blood; Progesterone -- blood; Prolactin -- blood; Thyrotropin -- blood; Assisted reproductive technology; Breast cancer; Ovarian reserve; Premature ovarian insufficiency
Description: The POSITIVE trial showed that premenopausal women with breast cancer (BC) can safely pause adjuvant endocrine treatment (ET) to attempt conception. 74 % of patients conceived spontaneously or through assisted reproductive technology (ART); Investigating hormonal factors that predict fertility was a key secondary endpoint. ; info:eu-repo/semantics/published
Document Type: article in journal/newspaper
File Description: 2 full-text file(s): application/pdf | application/pdf
Language: English
Relation: uri/info:doi/10.1016/j.breast.2025.104547; uri/info:pmid/40743662; uri/info:pmcid/PMC12336806; https://dipot.ulb.ac.be/dspace/bitstream/2013/396394/5/DemeesterePOSITIVE2025.pdf; https://dipot.ulb.ac.be/dspace/bitstream/2013/396394/1/elsevier_380038.pdf
Availability: https://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/396394; https://dipot.ulb.ac.be/dspace/bitstream/2013/396394/5/DemeesterePOSITIVE2025.pdf; https://dipot.ulb.ac.be/dspace/bitstream/2013/396394/1/elsevier_380038.pdf
Accession Number: edsbas.E1AF8430
Database: BASE